Gainers

• BNB Plus (NASDAQ:BNBX) stock moved upwards by 12.7% to $0.65 during Tuesday's after-market session. The market value of their outstanding shares is at $3.1 million.
• Hoth Therapeutics (NASDAQ:HOTH) stock rose 7.58% to $0.69. The market value of their outstanding shares is at $9.7 million.
• Actuate Therapeutics (NASDAQ:ACTU) shares moved upwards by 5.76% to $2.2. The company's market cap stands at $43.1 million.
• Vistagen Therapeutics (NASDAQ:VTGN) shares rose 5.66% to $0.63. The market value of their outstanding shares is at $22.8 million.
• OKYO Pharma (NASDAQ:OKYO) stock increased by 5.6% to $1.67. The company's market cap stands at $80.2 million.
• Bioventus (NASDAQ:BVS) stock rose 5.13% to $10.42. The company's market cap stands at $630.1 million.

Losers

• HeartBeam (NASDAQ:BEAT) stock fell 16.7% to $1.0 during Tuesday's after-market session. The market value of their outstanding shares is at $49.3 million.
• Aligos Therapeutics (NASDAQ:ALGS) shares decreased by 14.19% to $7.5. The market value of their outstanding shares is at $53.4 million.
• Immunic (NASDAQ:IMUX) shares decreased by 12.71% to $1.03. The company's market cap stands at $146.7 million.
• Wellgistics Health (NASDAQ:WGRX) stock decreased by 12.08% to $0.13. The company's market cap stands at $15.2 million.
• Clearmind Medicine (NASDAQ:CMND) shares declined by 8.69% to $0.83. The market value of their outstanding shares is at $3.4 million.
• Zentek (NASDAQ:ZTEK) stock declined by 7.87% to $0.47. The market value of their outstanding shares is at $58.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.